ArticleTherapeutic advances in medical oncology2024

Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional, propensity score-matching cohort analysis.

Qiaofeng Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.